Giredestrant tartrate (Estrogen receptor antagonist 1) is a novel, orally active, selective and effective non-steroidal estrogen receptor antagonist. Giredestrant tartrate strongly binds to ER, resulting in the failure of ER to activate the transcription of targeted genes and promoting the degradation of ER protein. Giredestrant tartrate can be used to treat tumor diseases.
Molecular Weight:
672.64
Purity:
97.01%
CAS Number:
[2407529-33-1]
Formula:
C31H37F5N4O7
Target:
Estrogen Receptor/ERR
T11236
* VAT and and shipping costs not included. Errors and price changes excepted